πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 137 of 173

  1. US 7323174

    Modulation of immune response and methods based thereon

    Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7323297

    Stabilized polynucleotide complexes and methods

    Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7323165

    Production of pancreatic islet cells and delivery of insulin

    Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7323334

    Screening and therapeutic methods relating to neurogenesis

    Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7323173

    Methods for treating breast cancer using a mammary cell growth inhibitor

    Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7323171

    Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction

    Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7323166

    Lactic acid bacteria cultures that inhibit food-borne pathogens

    Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7320783

    Methods and compositions for the enhancement of wound healing

    Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7321065

    Thyronamine derivatives and analogs and methods of use thereof

    Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7319015

    Methods and compositions for using alveolar macrophage phospholipase A2

    Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7319000

    Compositions and methods for eliciting immune or anti-infective responses

    Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7319134

    Regulation of transcription factor, NF-IL6/LAP

    Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7317020

    Isolation and structure of Cribrostatin 6

    Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7314917

    Modified vitamin K-dependent polypeptides

    Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7314624

    Nanoemulsion vaccines

    Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7314858

    Retrocyclins: antiviral and antimicrobial peptides

    Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7314911

    Prostate hyperplasia therapy

    Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7314615

    IΞΊB Kinase-Ξ² (IKKΞ²) binding antibodies and methods of using same

    Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7312226

    Substituted tricyclic compounds as protein kinase inhibitors

    Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7311921

    Multi-subtype FIV vaccines

    Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7312202

    Rationally designed and chemically synthesized promoter for genetic vaccine and gene therapy

    Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7311911

    Methods for inhibiting angiogenesis

    Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7309792

    Dimeric small molecule potentiators of apoptosis

    Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7309495

    Hemorrhagic feline calicivirus

    Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7309692

    Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1

    Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7309774

    Antiplasmin cleaving enzyme

    Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7306627

    Acellular matrix grafts of collagen and elastic fiber

    Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7306804

    HIV-specific T-cell induction

    Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7306946

    Antifungal polypeptides

    Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7307103

    Sodium dodecyl sulfate compositions for inactivating prions

    Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7303887

    Mule: Mcl-1 ubiquitination ligase E3

    Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7300920

    Antiangiogenic peptide agents

    Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7300774

    Multimeric fusion proteins of the TNF superfamily ligands

    Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7300915

    Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain

    Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7300660

    Abundant extracellular products and methods for their production and use

    Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7297488

    Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase

    Expires Mon Nov 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7294699

    Modified vitamin K-dependent polypeptides

    Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7294496

    Cloned human lysophospholipase

    Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7291336

    Compositions and methods for enhancing immune responses mediated by antigen-presenting cells

    Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7291699

    Product and methods for diagnosis and therapy for cardiac and skeletal muscle disorders

    Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7291348

    Compositions and methods for biodegradable microspheres as carriers of bioactive substances

    Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7288671

    Interleukin-1 and tumor necrosis factor-Ξ± modulators, synthesis of said modulators and their enantiomers and methods of using said modulators

    Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7288646

    USPA2 nucleic acid of Moraxella catarrhalis

    Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7288608

    Degradable thiol-ene polymers

    Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7288369

    Replication competent hepatitis C virus and methods of use

    Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7288246

    Method of alleviating chronic pain via peripheral glutaminase regulation

    Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7285281

    Mutant forms of cholera holotoxin as an adjuvant

    Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7285556

    Thienopyrimidine-based inhibitors of the src family

    Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.